Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0137 USD | -31.50% | -31.50% | -88.91% |
15/03 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
12/03 | News Highlights : Top Company News of the Day - Tuesday at 5 AM ET | DJ |
Business Summary
Number of employees: 949
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Scilex
60.5
%
| 29 | 54.0 % | 38 | 60.5 % | +33.24% |
Sorrento Therapeutics
39.5
%
| 24 | 46.0 % | 25 | 39.5 % | +1.84% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 53 | 100.0 % | 63 | 100.0 % | +18.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Henry Ji
CEO | Chief Executive Officer | 59 | 01/89/01 |
Shawn Sahebi
COO | Chief Operating Officer | - | - |
Mike A. Royal
CTO | Chief Tech/Sci/R&D Officer | 70 | 03/14/03 |
Director/Board Member | 60 | 01/17/01 | |
Jaisim Shah
BRD | Director/Board Member | 63 | 11/13/11 |
Brian Cooley
IRC | Investor Relations Contact | - | - |
William Farley
SAM | Sales & Marketing | 68 | - |
Alexis Nahama
PRN | Corporate Officer/Principal | - | 01/17/01 |
General Counsel | - | 01/17/01 | |
Mohsin Meghji
PRN | Corporate Officer/Principal | 60 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kim D. Janda
BRD | Director/Board Member | 67 | 01/12/01 |
David Lemus
BRD | Director/Board Member | 61 | 01/17/01 |
Jaisim Shah
BRD | Director/Board Member | 63 | 11/13/11 |
Yue Wu
BRD | Director/Board Member | 62 | 01/16/01 |
Henry Ji
CEO | Chief Executive Officer | 59 | 01/89/01 |
Director/Board Member | 60 | 01/17/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 558,849,336 | 546,375,093 ( 97.77 %) | 7,568,182 ( 1.354 %) | 97.77 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
SCILEX HOLDING COMPANY 1.15% | 1,917,210 | 1.15% | 3,048,364 $ |
CELULARITY INC. 2.32% | 505,043 | 2.32% | 2,641,375 $ |
Company contact information
Sorrento Therapeutics, Inc.
4955 Directors Place
92121, San Diego
+858 203 4100
http://sorrentotherapeutics.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-88.91% | 7.45M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- SRNE Stock
- Company Sorrento Therapeutics, Inc.